Notes - Segment Information

Astellas Pharma Inc. - Filing #7303078

Concept As at
2024-09-30
2024-04-01 to
2024-09-30
As at
2024-03-31
2023-04-01 to
2023-09-30
Notes - Segment information
Segment information
Revenue
Revenue
935,621,000,000 JPY
767,138,000,000 JPY
Share of profit (loss) of investments accounted for using equity method
1,448,000,000 JPY
-237,000,000 JPY
Profit (loss) before tax
89,042,000,000 JPY
56,318,000,000 JPY
Assets
3,462,237,000,000 JPY
3,569,603,000,000 JPY
Investments accounted for using equity method
18,141,000,000 JPY
15,684,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.